{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:12:13Z","timestamp":1773144733677,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,4,19]],"date-time":"2005-04-19T00:00:00Z","timestamp":1113868800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1007\/s00280-005-1016-1","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T13:37:09Z","timestamp":1113831429000},"page":"415-420","source":"Crossref","is-referenced-by-count":12,"title":["Exploratory study of drug plasma levels during bicalutamide 150\u00a0mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer"],"prefix":"10.1007","volume":"56","author":[{"given":"Francesco","family":"Boccardo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Rubagotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giario","family":"Conti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Potenzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Manganelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demetrio Del","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,4,19]]},"reference":[{"key":"1016_CR1","first-page":"400","volume":"22","author":"F Boccardo","year":"2003","unstructured":"Boccardo F, Rubagotti A, Garofalo L, Di Tonno P, Conti G, Bertaccini A, De Antoni P, Galassi P, Siragusa A, Durand F (2003) Tamoxifen is more effective than anastrozole in preventing gynecomastia and breast pain induced by bicalutamide monotherapy in prostate cancer patients. Proc Am Soc Clin Oncol 22:400 (abstract)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"1016_CR2","first-page":"468S","volume":"9","author":"AU Buzdar","year":"2003","unstructured":"Buzdar AU (2003) Pharmacology and pharmacokinetics of the newer generation aromatase inhibitors. Clin Cancer Res 9:468S\u2013472S","journal-title":"Clin Cancer Res"},{"key":"1016_CR3","doi-asserted-by":"crossref","unstructured":"Cockshott ID (2004) Bicalutamide: clinical pharmacokinetics and metabolism. Clin Pharmacokinet (in press)","DOI":"10.2165\/00003088-200443130-00003"},{"key":"1016_CR4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00001813-199601000-00006","volume":"7","author":"A Kaisary","year":"1996","unstructured":"Kaisary A, Klarskov P, McKillop D (1996) Absence of hepatic enzyme induction in prostate cancer patients receiving \u2018Casodex\u2019 (bicalutamide). Anticancer Drugs 7:54\u201359","journal-title":"Anticancer Drugs"},{"key":"1016_CR5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0090-4295(00)00823-2","volume":"56","author":"DG McLeod","year":"2000","unstructured":"McLeod DG, Iversen P (2000) Gynecomastia in patients with prostate cancer: a review of treatment options. Urology 56:713\u2013720","journal-title":"Urology"},{"key":"1016_CR6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00003088-200342040-00004","volume":"42","author":"KC Morello","year":"2003","unstructured":"Morello KC, Wurz GT, DeGregorio MW (2003) Pharmacokinetics of selective estrogen receptor modulators. Clin Pharmacokinet 42:361\u2013372","journal-title":"Clin Pharmacokinet"},{"issue":"(Suppl 2","key":"1016_CR7","first-page":"120","volume":"90","author":"D Saltzstein","year":"2002","unstructured":"Saltzstein D, Cantwell A, Sieber P, Ross JR, Silvay-Mandeau O, Gallo J (2002) Prophylactic tamoxifen significantly reduces the incidence of bicalutamide-induced gynaecomastia and breast pain. BJU Int 90 (Suppl 2):120\u2013121","journal-title":"BJU Int"},{"key":"1016_CR8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1078-1439(00)00118-6","volume":"6","author":"WA See","year":"2001","unstructured":"See WA, McLeod D, Iversen P, Wirth M (2001) The bicalutamide Early Prostate Cancer program: demography. Urol Oncol 6:43\u201347","journal-title":"Urol Oncol"},{"key":"1016_CR9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0022-5347(05)64652-6","volume":"168","author":"WA See","year":"2002","unstructured":"See WA, Wirth MP, McLeod DG, Iversen P, Klimberg I, Gleason D, Chodak G, Montie J, Tyrrell C, Wallace DMA, Delaere KPJ, Vaage S, Tammela TLJ, Lukkarinen O, Persson B-E, Carroll K, Kolvenbag GJCM, on behalf of the Casodex Early Prostate Cancer Trialist Group (2002) Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program. J Urol 168:429\u2013435","journal-title":"J Urol"},{"key":"1016_CR10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/030006058601400309","volume":"14","author":"K Soininen","year":"1986","unstructured":"Soininen K, Kleimola T, Elomaa I, Salmo M, Rissanen P (1986) The steady-state pharmacokinetics of tamoxifen and its metabolites in breast cancer patients. J Int Med Res 14:162\u2013165","journal-title":"J Int Med Res"},{"key":"1016_CR11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000019526","volume":"33","author":"CJ Tyrrell","year":"1998","unstructured":"Tyrrell CJ, Denis L, Newling D, Soloway M, Channer K, Cockshott ID, on behalf of the \u2018Casodex\u2019 Study Group (1998) CasodexTM 10\u2013200\u00a0mg daily, used as monotherapy for the treatment of patients with advanced prostate cancer. An overview of the efficacy, tolerability and pharmacokinetics from three Phase II dose-ranging studies. Eur Urol 33:39\u201353","journal-title":"Eur Urol"},{"key":"1016_CR12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2165\/00003088-198815030-00003","volume":"15","author":"VJ Wiebe","year":"1988","unstructured":"Wiebe VJ, Benz CC, DeGregorio MW (1988) Clinical pharmacokinetics of drugs used in the treatment of breast cancer. Clin Pharmacokinet 15:180\u2013193","journal-title":"Clin Pharmacokinet"},{"key":"1016_CR13","doi-asserted-by":"crossref","unstructured":"Wirth MP, See WA, McLeod DG, Iversen P, Morris T, Carroll K, on behalf of the \u2018Casodex\u2019 Early Prostate Cancer Trialists\u2019 Group (2004) Bicalutamide (\u2018Casodex\u2019) 150\u00a0mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at 5.4\u00a0years\u2019 median follow-up. J Urol (in press)","DOI":"10.1097\/01.ju.0000140159.94703.80"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-005-1016-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-005-1016-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-005-1016-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T22:35:57Z","timestamp":1586212557000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-005-1016-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,19]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["1016"],"URL":"https:\/\/doi.org\/10.1007\/s00280-005-1016-1","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,19]]}}}